Publications in collaboration with researchers from Instituto de Investigación Sanitaria Biogipuzkoa (53)

2024

  1. Genomic Surveillance Uncovers a 10-Year Persistence of an OXA-24/40 Acinetobacter baumannii Clone in a Tertiary Hospital in Northern Spain

    International Journal of Molecular Sciences, Vol. 25, Núm. 4

2023

  1. Early biochemical analysis of COVID-19 patients helps severity prediction

    PLoS ONE, Vol. 18, Núm. 5 May

  2. Immune cell population and cytokine profiling suggest age dependent differences in the response to SARS-CoV-2 infection

    Frontiers in Aging, Vol. 4

  3. Impact of the progressive uptake of pneumococcal conjugate vaccines on the epidemiology and antimicrobial resistance of invasive pneumococcal disease in Gipuzkoa, northern Spain, 1998–2022

    Frontiers in Public Health, Vol. 11

  4. Phenotypic and Genotypic Antimicrobial Susceptibility Testing of Chlamydia trachomatis Isolates from Patients with Persistent or Clinical Treatment Failure in Spain

    Antibiotics, Vol. 12, Núm. 6

  5. Validation of an expanded, in-house library and an optimized preparation method for the identification of fungal isolates using MALDI-TOF mass spectrometry

    Medical mycology, Vol. 61, Núm. 4

2022

  1. Clinical evaluation of the Procleix SARS-CoV-2 assay, a sensitive, high-throughput test that runs on an automated system

    Diagnostic Microbiology and Infectious Disease, Vol. 102, Núm. 1

  2. Genomic features of predominant non-PCV13 serotypes responsible for adult invasive pneumococcal disease in Spain

    The Journal of antimicrobial chemotherapy, Vol. 77, Núm. 9, pp. 2389-2398

  3. Increases in the Macrolide Resistance of Mycoplasma genitalium and the Emergence of the A2058T Mutation in the 23S rRNA Gene: Clonal Spread?

    Antibiotics, Vol. 11, Núm. 11

2021

  1. Analysis of SARS-CoV-2 reverse transcription-quantitative polymerase chain reaction cycle threshold values vis-à-vis anti-SARS-CoV-2 antibodies from a high incidence region

    International Journal of Infectious Diseases, Vol. 110, pp. 114-122

  2. Antibacterial activity testing methods for hydrophobic patterned surfaces

    Scientific Reports, Vol. 11, Núm. 1

  3. Azole resistance survey on clinical Aspergillus fumigatus isolates in Spain

    Clinical Microbiology and Infection, Vol. 27, Núm. 8, pp. 1170.e1-1170.e7

  4. Clinical correlates of anti-SARS-CoV-2 antibody profiles in Spanish COVID-19 patients from a high incidence region

    Scientific Reports, Vol. 11, Núm. 1

  5. Comparison of four methods for streptococcus pneumoniae capsular typing

    Clinical Laboratory, Vol. 67, Núm. 7, pp. 1598-1602

  6. Diagnostic accuracy of adenosine deaminase for pleural tuberculosis in a low prevalence setting: A machine learning approach within a 7-year prospective multi-center study

    PLoS ONE, Vol. 16, Núm. 11 November

  7. Epidemiology of pneumococcal diseases in Spain after the introduction of pneumococcal conjugate vaccines

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 39, Núm. 3, pp. 142-150

  8. Multicenter evaluation of the Panbio™ COVID-19 rapid antigen-detection test for the diagnosis of SARS-CoV-2 infection

    Clinical Microbiology and Infection, Vol. 27, Núm. 5, pp. 758-761

  9. Neuroretinitis caused by Bartonella henselae in Gipuzkoa, 2014-2019

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 39, Núm. 9, pp. 451-453

  10. O group is a protective factor for COVID19 in Basque population

    PLoS ONE, Vol. 16, Núm. 4 April

2020

  1. A multicentre analysis of Nocardia pneumonia in Spain: 2010–2016

    International Journal of Infectious Diseases, Vol. 90, pp. 161-166